Physician profile
Farly Sejour
NPI 1225107113
$1,598.15
in general payments reported to CMS, 2019-2025
23 companies · $167 in 2025
The $167 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $95.31 · 2021: $479 · 2022: $247 · 2023: $168 · 2024: $228 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548 · Entertainment: $14.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.46 |
| Entertainment | $14.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $270.62 | 2020-2024 | Slynd |
| Inari Medical, INC. | $188.95 | 2021 | |
| Mayne Pharma Commercial LLC | $146.14 | 2021-2024 | |
| Coopersurgical, INC. | $140.82 | 2019-2023 | Advincula Delineator Uterine Manipulator |
| Shield Therapeutics INC | $83.89 | 2023-2024 | Accrufer |
| Biogen, INC. | $80.82 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $79.17 | 2019-2023 | Thinprep 2000 Processor |
| Abbvie INC. | $75.69 | 2020-2022 | |
| Myovant Sciences INC. | $66.93 | 2021-2022 | |
| Sage Therapeutics, LLC | $60.23 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.22 | 2019-2020 | |
| Pfizer INC. | $47.26 | 2024-2025 | |
| Astellas Pharma US INC | $41.05 | 2024 | Veozah |
| Allergan, INC. | $40.67 | 2019-2020 | |
| Evofem Biosciences, INC. | $37.16 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $37.10 | 2023-2024 | Cologuard Collection Kit |
| Baxter Healthcare | $33.52 | 2025 | Perclot |
| Medtronic, INC. | $28.21 | 2024 | Venaseal |
| Abbott Laboratories | $24.41 | 2021 | |
| Millicent US INC | $22.81 | 2025 | Femlyv |
| Organon LLC | $15.28 | 2022 | |
| Ethicon US, LLC | $14.78 | 2025 | Dermabond Prineo, Vistaseal, Surgicel Nu-Knit |
| Argentum Medical | $14.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farly Sejour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.